Archive | Avandia RSS feed for this section
New study confirms Avandia heart injury
A new analysis confirms that those who take the diabetes drug Avandia are more likely to develop heart problems and die than those who take a similar type of diabetes medication. Avandia helps control blood sugar levels in the body, and is prescribed for patients with type 2 diabetes. Studies in recent years have differed [...]
Continue reading...Avandia lawsuit
22. February 2011
Louisiana has filed a lawsuit against GlaxoSmithKline for fraud involving the diabetes drug Avandia, alleging that the drug maker hid information about potential side effects of Avandia. The Avandia suit was filed last week by Louisiana Attorney General Buddy Caldwell, claiming that GlaxoSmithKline collected more than $36 million in Medicaid reimbursements from the state as [...]
Continue reading...Avandia restricted to limited Type 2 diabetes patients
23. September 2010
The Food and Drug Administration announced Thursday that access to the diabetes drug Avandia will be restricted to patients with Type 2 diabetes whose condition cannot be controlled with other medications. Also Thursday, the European Medicines Agency recommended that Avandia be taken off the market. The EMA is Europe’s counterpart to the U.S. Food and [...]
Continue reading...Avandia may cause serious or even life-threatening heart problems
10. July 2010
Two new studies suggest Avandia may cause serious heart problems. FDA will reveal on Friday the data it is reviewing ahead of an advisory panel meeting about the safety of the popular diabetes drug. The meeting, scheduled for July 13 and 14, comes on the heels of two new studies suggesting that Avandia may cause [...]
Continue reading...Avandia may cause heart attacks
10. July 2010
GlaxoSmithKline misinterpreted crucial details of a study finding that Avandia, its blockbuster diabetes drug, is safe, a medical reviewer for the Food and Drug Administration said Friday. Correctly interpreted, the study actually supports critics’ contentions that Avandia may cause heart attacks, said the reviewer, Dr. Thomas Marciniak, in a posting on the F.D.A.’s Web site. The company’s misreadings of [...]
Continue reading...Government report links Avandia to heart attacks
20. February 2010
The diabetes drug Avandia produced by GlaxoSmithKline is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released on 20., February of 2010. The senate report by the Senate Finance Committee also criticized the [...]
Continue reading...Avandia Drug Recall
20. January 2009
Avandia produced by GlaxoSmithKline, is an oral diabetes medication intended to help those with type-2 diabetes better control their blood glucose levels. Generically classified as a thiazoliodinedione, Avandia is not indicated for those with insulin-dependent (type-1) diabetes. FDA scientists estimated in July 2007 that Avandia was associated with approximately 83,000 heart attacks since the drug came [...]
Continue reading...Avandia has been linked to Heart Attacks
27. July 2008
Avandia (rosiglitazone maleate) is a popular diabetes drug made by GlaxoSmithKline. A recent study by the FDA has lead to nationwide Avandia recall as the tablets have been shown to cause serious side effects including an increased risk of heart attack and cardiovascular diseases.
Continue reading...
- Risperdal (Resperidone)
- FDA issues warning on Advair, Symbicort, Foradil and Serevent
- Crestor Linked to Rhabdomyolysis (Fatal Muscle Disease)
- Benzoyl Peroxide Acne Cream 10% Contained Burkholderia Cepacia Bacteria
- Merck’s Vioxx $4.85 billion payouts to begin in August
- Zoloft lawsuit
- Fluoroquinolone Antimicrobial Drugs
- Arthritis Drug Vioxx Recalled
- Tysabri monotherapy and progressive multifocal leukoencephalopathy
- FDA recalls Zyprexa
- None found
- Pfizer birth control pills may not prevent pregnancy
- Adcetris brain infection death
- FDA warning on Multaq and Increased Risk of Death
- SSRI and Potential Risk of Persistent Pulmonary Hypertension
- Serious Complications Associated with Vaginal Mesh devices
- Actos Lawsuit
- Infant heart defect risks increase with SSRIs
- Birth defects more likely with SSRI use
- Diflucan during pregnancy poses risk to infants
- Birth defects caused by many factors
23. March 2011
0 Comments